Literature DB >> 3629198

Review of the NIMH Israeli Kibbutz-City Study and the Jerusalem Infant Development Study.

J Marcus, S L Hans, S Nagler, J G Auerbach, A F Mirsky, A Aubrey.   

Abstract

The National Institute of Mental Health (NIMH) Israeli Kibbutz-City Study has followed the development of offspring of schizophrenic parents from middle childhood through early adulthood. During childhood, a subgroup of offspring of schizophrenic patients showed clear neurobehavioral deficits often accompanied by poor social competence. Early followup data suggest that this subgroup of high-risk children is at greatest risk for adult schizophrenia spectrum illness. The Jerusalem Infant Development Study has followed a similar population of children at risk for schizophrenia from before birth through middle childhood. A subgroup of dysfunctioning in the high-risk children showed sensorimotor dysfunctioning in the first year of life, which was followed by perceptual, motor, and attentional dysfunctioning in childhood--identical to that found in the NIMH cohort. Results from both studies support the hypothesis that schizophrenic illness involves constitutional factors whose expression can be observed as early as infancy. Results also illustrate the importance of using data-analytic approaches that (1) look for subgroups within high-risk groups rather than only group differences between high- and low-risk groups, and (2) examine profiles of behavior rather than only single variables.

Entities:  

Mesh:

Year:  1987        PMID: 3629198     DOI: 10.1093/schbul/13.3.425

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  9 in total

1.  Specificity of familial transmission of schizophrenia psychosis spectrum and affective psychoses in the New England family study's high-risk design.

Authors:  Jill M Goldstein; Stephen L Buka; Larry J Seidman; Ming T Tsuang
Journal:  Arch Gen Psychiatry       Date:  2010-05

2.  Interpersonal behavior of preschizophrenic children: a study of home-movies.

Authors:  J Litter; E Walker
Journal:  Child Psychiatry Hum Dev       Date:  1993

Review 3.  Neurocognition in youth and young adults under age 30 at familial risk for schizophrenia: a quantitative and qualitative review.

Authors:  Jessica Agnew-Blais; Larry J Seidman
Journal:  Cogn Neuropsychiatry       Date:  2012-09-21       Impact factor: 1.871

4.  Attentional and neurocognitive characteristics of high-risk offspring of parents with schizophrenia compared with DSM-IV attention deficit hyperactivity disorder children.

Authors:  Ozgür Oner; Kerim Munir
Journal:  Schizophr Res       Date:  2005-07-15       Impact factor: 4.939

5.  Childhood motor coordination and adult schizophrenia spectrum disorders.

Authors:  Jason Schiffman; Holger J Sorensen; Justin Maeda; Erik L Mortensen; Jeff Victoroff; Kentaro Hayashi; Niels M Michelsen; Morten Ekstrom; Sarnoff Mednick
Journal:  Am J Psychiatry       Date:  2009-07-15       Impact factor: 18.112

6.  Premorbid cognitive deficits in young relatives of schizophrenia patients.

Authors:  Matcheri S Keshavan; Shreedhar Kulkarni; Tejas Bhojraj; Alan Francis; Vaibhav Diwadkar; Debra M Montrose; Larry J Seidman; John Sweeney
Journal:  Front Hum Neurosci       Date:  2010-03-09       Impact factor: 3.169

7.  Methylphenidate-induced mania-like symptoms.

Authors:  Kaustav Chakraborty; Sandeep Grover
Journal:  Indian J Pharmacol       Date:  2011-02       Impact factor: 1.200

8.  Defective processing speed and nonclinical psychotic experiences in children: longitudinal analyses in a large birth cohort.

Authors:  Maria Niarchou; Stanley Zammit; James Walters; Glyn Lewis; Michael John Owen; Marianne Bernadette van den Bree
Journal:  Am J Psychiatry       Date:  2013-05       Impact factor: 18.112

9.  Trajectories of Early Childhood Developmental Skills and Early Adolescent Psychotic Experiences: Findings from the ALSPAC UK Birth Cohort.

Authors:  Mohajer A Hameed; Raghu Lingam; Stanley Zammit; Giovanni Salvi; Sarah Sullivan; Andrew J Lewis
Journal:  Front Psychol       Date:  2018-01-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.